Familial antithrombin III deficiency

67Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

Antithrombin III is the major physiological inhibitor of the coagulation mechanism and a deficiency of this protein results in a marked predisposition to venous thromboembolic disease. Three Scottish families with a deficiency of this protein are described and other reported families are reviewed. The properties, functions and methods of assay of antithrombin III are outlined; the molecular abnormalities, inheritance, clinical and laboratory characteristics of antithrombin III deficiency are described, and the use of antithrombotic drugs and human antithrombin III concentrates in this deficiency is discussed.

Cite

CITATION STYLE

APA

Winter, J. H., Fenech, A., Ridley, W., Bennett, B., Cumming, A. M., Mackie, M., & Douglas, A. S. (1982). Familial antithrombin III deficiency. Quarterly Journal of Medicine, 51(204), 373–395. https://doi.org/10.1097/00005792-198307000-00002

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free